zithromax and Brain-Diseases

zithromax has been researched along with Brain-Diseases* in 2 studies

Other Studies

2 other study(ies) available for zithromax and Brain-Diseases

Article	Year
Pertussis encephalopathy in an infant. Archives of disease in childhood, 2013, Volume: 98, Issue:2 Topics: Anti-Bacterial Agents; Azithromycin; Bordetella pertussis; Brain Diseases; Humans; Infant; Magnetic Resonance Imaging; Male; Treatment Outcome; Whooping Cough	2013
Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii. Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:5 Doses of 200 mg of azithromycin per kg (body weight) administered by the oral route daily for 10 days completely protected mice against death caused by intraperitoneal infection with Toxoplasma gondii. The same treatment regimen also protected 80% of mice infected intracerebrally, which suggests that azithromycin attains active concentrations in the inflamed central nervous system. Topics: Animals; Azithromycin; Brain Diseases; Erythromycin; Mice; Peritonitis; Toxoplasmosis, Animal	1988

Article

Year

Archives of disease in childhood, 2013, Volume: 98, Issue:2

Topics: Anti-Bacterial Agents; Azithromycin; Bordetella pertussis; Brain Diseases; Humans; Infant; Magnetic Resonance Imaging; Male; Treatment Outcome; Whooping Cough

2013

Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii.

Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:5

Doses of 200 mg of azithromycin per kg (body weight) administered by the oral route daily for 10 days completely protected mice against death caused by intraperitoneal infection with Toxoplasma gondii. The same treatment regimen also protected 80% of mice infected intracerebrally, which suggests that azithromycin attains active concentrations in the inflamed central nervous system.

Topics: Animals; Azithromycin; Brain Diseases; Erythromycin; Mice; Peritonitis; Toxoplasmosis, Animal

1988